XML 20 R3.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Oct. 03, 2025
Sep. 27, 2024
Sep. 29, 2023
Income Statement [Abstract]      
Revenues, net $ 844.6 $ 811.0 $ 893.4
Cost of revenues 554.1 554.1 603.1
Gross profit 290.5 256.9 290.3
Operating expenses:      
Research and development 91.1 87.0 84.8
Selling, general, and administrative 133.3 137.8 128.4
Impairment of goodwill 93.9 0.0 0.0
Total operating expenses 318.3 224.8 213.2
Operating (loss) income (27.8) 32.1 77.1
Interest income 8.5 7.3 3.7
Interest expense (35.5) (30.2) (29.3)
Other expense, net (4.4) (4.2) (20.2)
Interest and other expense, net (31.4) (27.1) (45.8)
(Loss) income before taxes (59.2) 5.0 31.3
Income tax expense (benefit) 10.7 53.3 (16.6)
Net (loss) income (69.9) (48.3) 47.9
Less: Net income attributable to noncontrolling interests 0.4 0.5 0.5
Net (loss) income attributable to Varex $ (70.3) $ (48.8) $ 47.4
Net (loss) income per common share attributable to Varex      
Basic (in USD per share) $ (1.70) $ (1.20) $ 1.18
Diluted (in USD per share) $ (1.70) $ (1.20) $ 1.07
Weighted average common shares outstanding      
Basic (in shares) 41.4 40.8 40.3
Diluted (in shares) 41.4 40.8 50.3